Back to Journals » Biologics: Targets and Therapy » Volume 3

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

Total article views   HTML views PDF downloads Totals
13,487 Dovepress* 13,487+ 2,500 15,987
Totals 13,487 2,500 15,987
*Since 17 June 2009
+Since July 2016

View citations on Google Scholar